PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
01-Feb-2024 Global DLL3 Targeted Therapies Market Opportunities & Clinical Trials Insight 2024: Insights On 10 Current & Potential Proprietary Platforms, Company, Indication & Phase for 15 Drugs, and 14 Companies - ResearchAndMarkets.com Businesswire
01-Feb-2024 NeoGenomics Signs Working with Cancer Pledge in Support of Employees Businesswire
01-Feb-2024 ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke Businesswire
01-Feb-2024 Deciphera Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference Businesswire
01-Feb-2024 Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance Businesswire
01-Feb-2024 Antibe Extends Early Warrant Exercise Incentive Program Businesswire
01-Feb-2024 Deb Autor, Former FDA Deputy Commissioner, Appointed CEO of Healthcare Innovation Catalysts Businesswire
01-Feb-2024 Voom Medical Devices Welcomes Dr. Joël Vernois as Advisor and Editor-in-Chief of Journal of Minimally Invasive Bunion Surgery (JMIBS) Businesswire
01-Feb-2024 Merck Announces Fourth-Quarter and Full-Year 2023 Financial Results Businesswire
01-Feb-2024 Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2023 Businesswire
01-Feb-2024 Ventegra Announces Its ‘Great Place to Work®’ Certification Businesswire
01-Feb-2024 Revelation Biosciences Inc. Announces Pricing of $6.2 Million Public Offering Businesswire
01-Feb-2024 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
01-Feb-2024 Resalis Therapeutics Appoints Almut Nitsche as Chief Medical and Development Officer Businesswire
01-Feb-2024 AmplifyBio Celebrates Grand Opening of Manufacturing Enablement Center in New Albany, Ohio Newswire
01-Feb-2024 Solidsoft Reply Spearheads Ground-breaking Migration of Finland’s National Medicines Verification System Businesswire
01-Feb-2024 Seroba Announces Above Target Final Close of its Fund IV at €123M ($134M) Businesswire
01-Feb-2024 Arkema Completes Its 40% Increase in Global Pebax® Elastomers Production Capacity Businesswire
01-Feb-2024 Takeda Announces Chief Financial Officer Succession Businesswire
01-Feb-2024 Sensorion Announces the Completion of Patient Inclusion in Phase 2a Clinical Trial of SENS-401 for Residual Hearing Preservation After Cochlear Implantation Businesswire